Over the past few years, the contribution of oxysterols to the onset and development of some of the major neurodegenerative diseases (such as Alzheimer's and Parkinson's diseases) has been scientifically asserted, being mainly related to altered brain cholesterol homeostasis. To counteract oxysterol induced inflammation at neuronal level, one possible intervention approach is the administration of some nutrients and/or plant secondary metabolites. On the other hand, the pleiotropic beneficial effects of physical activity seem to play an important role on prevention and counteraction of neurodegenerative diseases, through the modulation of oxysterol homeostasis and the prevention of demyelination. The present review provides a picture of the promising role of nutraceuticals and physical activity on oxysterol-mediated neurodegeneration, pointing out also the different in vitro and in vivo aspects that need to be further investigated for a better understanding of the association of these three counterparts and their overall effect on people at increased risk for neurodegenerative diseases.

Nutraceuticals and physical activity: Their role on oxysterols-mediated neurodegeneration

Cardenia V.
Co-first
;
2019-01-01

Abstract

Over the past few years, the contribution of oxysterols to the onset and development of some of the major neurodegenerative diseases (such as Alzheimer's and Parkinson's diseases) has been scientifically asserted, being mainly related to altered brain cholesterol homeostasis. To counteract oxysterol induced inflammation at neuronal level, one possible intervention approach is the administration of some nutrients and/or plant secondary metabolites. On the other hand, the pleiotropic beneficial effects of physical activity seem to play an important role on prevention and counteraction of neurodegenerative diseases, through the modulation of oxysterol homeostasis and the prevention of demyelination. The present review provides a picture of the promising role of nutraceuticals and physical activity on oxysterol-mediated neurodegeneration, pointing out also the different in vitro and in vivo aspects that need to be further investigated for a better understanding of the association of these three counterparts and their overall effect on people at increased risk for neurodegenerative diseases.
2019
193
105430
105438
Bioactive compounds; Neurodegenerative diseases; Nutraceuticals; Oxysterols; Physical activity; Animals; Humans; Neurodegenerative Diseases; Oxysterols; Dietary Supplements; Exercise
Malaguti M.; Cardenia V.; Rodriguez-Estrada M.T.; Hrelia S.
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0960076019301608-main(1).pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 373.63 kB
Formato Adobe PDF
373.63 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Deroga.pdf

Accesso riservato

Descrizione: deroga
Tipo di file: DEROGA (OBBLIGATORIO ALLEGARE FILE CON MOTIVAZIONE)
Dimensione 20.8 kB
Formato Adobe PDF
20.8 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1776296
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact